- Home
- CTMX vs DTSQ Comparison
CTMX vs DTSQ Comparison
Compare CTMX & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- DTSQ
- Stock Information
- Founded
- CTMX 2008
- DTSQ 2022
- Country
- CTMX United States
- DTSQ United States
- Employees
- CTMX N/A
- DTSQ N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- DTSQ
- Sector
- CTMX Health Care
- DTSQ
- Exchange
- CTMX Nasdaq
- DTSQ NYSE
- Market Cap
- CTMX 444.3M
- DTSQ 91.7M
- IPO Year
- CTMX 2015
- DTSQ 2024
- Fundamental
- Price
- CTMX $2.27
- DTSQ $10.38
- Analyst Decision
- CTMX Strong Buy
- DTSQ
- Analyst Count
- CTMX 2
- DTSQ 0
- Target Price
- CTMX $5.00
- DTSQ N/A
- AVG Volume (30 Days)
- CTMX 2.7M
- DTSQ 536.0
- Earning Date
- CTMX 08-07-2025
- DTSQ 01-01-0001
- Dividend Yield
- CTMX N/A
- DTSQ N/A
- EPS Growth
- CTMX 128.27
- DTSQ N/A
- EPS
- CTMX 0.49
- DTSQ 0.28
- Revenue
- CTMX $147,557,000.00
- DTSQ N/A
- Revenue This Year
- CTMX N/A
- DTSQ N/A
- Revenue Next Year
- CTMX N/A
- DTSQ N/A
- P/E Ratio
- CTMX $4.78
- DTSQ $37.03
- Revenue Growth
- CTMX 23.81
- DTSQ N/A
- 52 Week Low
- CTMX $0.40
- DTSQ $9.96
- 52 Week High
- CTMX $3.10
- DTSQ $10.47
- Technical
- Relative Strength Index (RSI)
- CTMX 50.77
- DTSQ N/A
- Support Level
- CTMX $2.08
- DTSQ N/A
- Resistance Level
- CTMX $2.44
- DTSQ N/A
- Average True Range (ATR)
- CTMX 0.24
- DTSQ 0.00
- MACD
- CTMX -0.08
- DTSQ 0.00
- Stochastic Oscillator
- CTMX 19.12
- DTSQ 0.00
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.